Exploring the Role of a Novel HPV16-Targeted Cancer Vaccine (Versamune® HPV) for Human Papilloma Virus (HPV) Positive Head and Neck Cancer (HNSCC) - Episode 1

Introduction and Incidence of HPV-Positive Head and Neck Cancer

A panelist discusses the incidence of HPV+ HNSCC, and how has it changed in recent years.

Now Viewing
EP. 1: Introduction and Incidence of HPV-Positive Head and Neck Cancer

Video content above is prompted by the following:

Current Incidence of HPV+ HNSCC 

  • Please discuss the current incidence of HPV+ HNSCC, and how has it changed in recent years?
  • Please address specific populations or demographics most affected
  • What are the main differences between HPV+ and HPV- HNSCCs in terms of biology and patient outcomes?